Medical Care Technologies reaches definitive agreement to acquire GUC's technologies

Medical Care Technologies Inc. (OTCBB: MDCE) today announced that it has reached a definitive agreement to acquire various technologies from Great Union Corporation, ("GUC") a private Hong Kong corporation.

The Boards of Directors of both companies have unanimously approved the transaction.

Pursuant to the Agreement, and in consideration of 57,300,000 of its common stock, MDCE will acquire GUC's technologies associated with the development and maintenance of secure information systems which increase access to medical resources services, education and wellness, pharmaceutical and nutraceutical products. The transaction is subject to customary closing conditions.

Management believes that the acquisition is a significant step in MDCE's strategy to enter into China's lucrative health care market. With life expectancy of the Chinese population gradually increasing, and as China's population becomes wealthier, patients are demanding better lifestyles and better quality care.

According to the US World Nutraceutical Ingredients Industry, it states that the "World demand for nutrients and minerals is projected to reach $12.6 billion in 2013, it too has predicted that China and India will emerge as the most rapidly expanding nutraceutical ingredient markets as strong economic growth allows them to upgrade and diversify food, beverage and drug production capabilities." It also goes on to state, that "China will remain the largest worldwide producer based on its extensive fine chemicals industry and aggressive pursuit of exports."

In China alone nutraceutical sales are estimated to be worth approximately $6 billion in annual sales, according to the China Health Care Association, which is an association attached to China's Ministry of Health. Although the industry is young compared with the U.S., and about one-fourth its size, the potential for sizeable growth is significant due to China's rapid economic growth and increasing consumer demand for natural products that promote health and overall wellness.

Patricia Traczykowski, President of MDCE, goes on to state, "I am very excited for our shareholders and for the Company with our most recent acquisition. It is an acquisition which will allow us to target an expanding healthcare segment and will allow us to venture into a country like China which is full of opportunities. Our values will be simple, using technology to provide better health. We plan to offer affordable, standardized and secure software information systems to electronically connect Healthcare Providers, Academic Institutions, Pharmaceutical and Nutraceutical Companies, Alternative Health Industries, and Individual Consumers with healthcare information, products and services in China. Initially, we aim to generate e-management revenues and nutraceutical and pharmaceutical product distribution revenues. Concurrent with and in addition to our main revenue streams, we hope to add to our bottom line through content licensing fees, email marketing revenues and e-commerce."

Management intends to immediately begin the process of integrating its technology, services and products into Asia once the registration of the share transfer is completed and it has obtained transfer of the assets, all as contemplated by the Asset Acquisition Agreement.